Life Science Company News

Reset
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Nexstim Plc: Managers’ Transactions, Forss

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

Nexstim Plc: Managers’ Transactions, Hildén

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nexstim Plc

Parexel and Palantir Expand Collaboration to Accelerate Clinical Data Delivery and Power Clinical Outcomes for Patients

Read more ››
By: GlobeNewswire - 25 Apr 2024

Kymera Therapeutics to Report First Quarter 2024 Financial Results on May 2

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Kymera Therapeutics Inc.

Morphic Announces Corporate Highlights and Financial Results for the First Quarter 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Morphic Therapeutic, Inc.

TELA Bio to Announce First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  TELA Bio, Inc

Microbix Collaborator Introduces New Lab Accreditation Program

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Microbix Biosystems Inc.

Regeneron and Mammoth Biosciences Collaborate to Pursue Next-Generation CRISPR-Based Gene Editing for Multiple Diseases

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes Scientific Advisory Board of world-leading experts

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Nucleome Therapeutics Limited

BioXcel Therapeutics to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  BioXcel Therapeutics, Inc.

Optinose Provides Corporate Update on XHANCE Launch and Outlook and Announces Preliminary First Quarter 2024 XHANCE Net Revenue of $14.9 million

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  OptiNose US Inc.

Sweetwater Brewing Unveils Modern Rebrand

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Tilray Inc.

Eyenovia Provides Clinical and Scientific Update on FDA-Approved Products Mydcombi™ and Clobetasol Propionate Ophthalmic Suspension

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Eyenovia, Inc.

HOOKIPA Pharma Announces Pivotal Phase 2/3 Trial Design for HB-200 in Combination with Pembrolizumab

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Hookipa Pharma Inc.

Jushi Holdings Inc. to Report First Quarter 2024 Financial Results on May 9, 2024

Read more ››
By: GlobeNewswire - 25 Apr 2024

Kura Oncology to Report First Quarter 2024 Financial Results

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Kura Oncology, Inc.

XOMA Earns $9 Million Milestone as FDA Grants Accelerated Approval to Day One’s OJEMDATM (tovorafenib) for Relapsed or Refractory BRAF-altered Pediatric Low-Grade Glioma (pLGG)

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  XOMA Corporation

UNITY Biotechnology Announces Upcoming Presentations at the ARVO 2024 Annual Meeting

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  Unity Biotechnology Inc

BioVie Presents Data Showing Potential for Bezisterim (NE3107) to Reduce Inflammation and Restore Homeostasis in a Manner Correlated with Alzheimer’s Disease and Biomarker Endpoints

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  BioVie Inc.

DiagnaMed’s BRAIN AGE® Brain Health AI Platform Accomplishes Clinical Validation Milestone with Peer-Reviewed Paper

Read more ››
By: GlobeNewswire - 25 Apr 2024
Related companies:  DiagnaMed Holdings Corp.
Results 1 - 20 out of 500 displayed.
1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate
Try for free »